Literature DB >> 3494747

Demyelination and neurological signs in experimental allergic encephalomyelitis.

M P Pender.   

Abstract

Because of the reported absence of demyelination in some animals with neurological signs of experimental allergic encephalomyelitis (EAE), it has been suggested that these signs are not due to demyelination. The present study demonstrates that there is ample demyelination in the central nervous system (CNS) and peripheral nervous system (PNS) to account for the neurological signs in rats with myelin basic protein (MBP)-induced acute EAE as well as in rats and rabbits with whole-spinal-cord-induced acute EAE. The main reasons for failure to detect demyelination in animals with neurological signs of EAE appear to be inadequate histological techniques and incomplete examination of the nervous system, particularly the PNS and the lumbar, sacral and coccygeal segments of the spinal cord.

Entities:  

Mesh:

Year:  1987        PMID: 3494747     DOI: 10.1016/0165-5728(87)90003-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.

Authors:  Anne I Boullerne; Jose J Rodriguez; Tarik Touil; Bruno Brochet; Stephan Schmidt; Nora D Abrous; Michel Le Moal; Jeffrey R Pua; Mark A Jensen; Willy Mayo; Barry G W Arnason; Klaus G Petry
Journal:  J Neurosci       Date:  2002-01-01       Impact factor: 6.167

Review 2.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

3.  The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.

Authors:  M P Pender; G P Stanley; G Yoong; K B Nguyen
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis.

Authors:  C Linington; H Lassmann; B P Morgan; D A Compston
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Bringing CLARITY to gray matter atrophy.

Authors:  Rory D Spence; Florian Kurth; Noriko Itoh; Chandler R L Mongerson; Shannon H Wailes; Mavis S Peng; Allan J MacKenzie-Graham
Journal:  Neuroimage       Date:  2014-07-16       Impact factor: 6.556

6.  Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.

Authors:  I Huitinga; S R Ruuls; S Jung; N Van Rooijen; H P Hartung; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

7.  Lymphocyte-myelin sheath interactions in acute experimental allergic encephalomyelitis.

Authors:  W F Blakemore; B A Summers; J Sedgwick
Journal:  J Neuroimmunol       Date:  1989-06       Impact factor: 3.478

8.  Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control.

Authors:  C Bolton
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

9.  Cytotoxic effect of myelin basic protein-reactive T cells on cultured oligodendrocytes.

Authors:  K Kawai; B Zweiman
Journal:  J Neuroimmunol       Date:  1988-08       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.